On the other hand, ACE2 expressed in multiple extrapulmonary tissues along with dysregulation of immune responses and the interaction between ACE2 and TMPRSS2 could be decisive for extrapulmonary manifestations and the clinical outcome of COVID-19 (Gupta et al., 2020; Zipeto et al., 2020). Here, ACE2 is linked to COVID-19.